Altium Capital is a New York-based healthcare investment firm specializing in mid- and small-cap equities, both public and private. Founded in 2017 by Jacob Gottlieb, the firm focuses on providing growth capital to companies developing novel technologies for human health. Altium typically engages in various investment rounds, including post-IPO equity, Series B, Series C, and seed investments.
Notable portfolio companies include Aligned, Antios Therapeutics, eGenesis, Ocuphire Pharma, Outlook Therapeutics, Palisade Bio, and X4 Pharmaceuticals. CEO Jacob Gottlieb brings extensive experience from healthcare hedge funds, private equity, and venture capital. Altium's team comprises scientific professionals and seasoned fund managers, offering unique value-add services such as strategic guidance and business management support to their portfolio companies.
Altium Capital - Portfolio Snapshot
Portfolio activity breakdown across disclosed investments and stages
